Want to see GB:TRLS full AI Analyst Report?
Trellus Health PLC (TRLS) Ratios
Trellus Health PLC Ratios
GB:TRLS's free cash flow for Q2 2025 was $-2.53M. For the 2025 fiscal year, GB:TRLS's free cash flow was increased by $0.00 and operating cash flow was $-2.53M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 12.15 | 15.69 | 23.56 | 21.32 | 30.29 |
| Quick Ratio | 12.15 | 15.69 | 23.56 | 21.32 | 30.29 |
| Cash Ratio | 11.71 | 15.48 | 23.22 | 21.03 | 30.20 |
| Solvency Ratio | -18.64 | -7.98 | -10.07 | -3.86 | -12.48 |
| Operating Cash Flow Ratio | -19.73 | -6.71 | -10.49 | -3.14 | -10.66 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 4.14M | $ 11.54M | $ 18.55M | $ 30.91M | $ 3.57M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.03 | 1.04 | 1.03 | 1.04 | 1.03 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.61 | 1.87 | 2.31 | 5.45 | 2.42 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| EBIT Margin | -7041.23% | -34536.84% | -48944.44% | -23608.00% | 0.00% |
| EBITDA Margin | -6281.58% | -34194.74% | -45966.67% | -23480.00% | 0.00% |
| Operating Profit Margin | -7041.23% | -35805.26% | -48944.44% | -23608.00% | 0.00% |
| Pretax Profit Margin | -6826.32% | -33363.16% | -48944.44% | -23608.00% | 0.00% |
| Net Profit Margin | -6826.32% | -33363.16% | -48944.44% | -23608.00% | 0.00% |
| Continuous Operations Profit Margin | -6826.32% | -33363.16% | -48944.44% | -23608.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 96.95% | 93.18% | 100.00% | 100.00% | 100.00% |
| Return on Assets (ROA) | -64.11% | -31.25% | -34.00% | -16.04% | -34.89% |
| Return on Equity (ROE) | -66.13% | -32.51% | -35.11% | -16.73% | -35.89% |
| Return on Capital Employed (ROCE) | -68.22% | -34.89% | -35.11% | -16.73% | -35.89% |
| Return on Invested Capital (ROIC) | -68.22% | -34.89% | -35.11% | -16.73% | -35.89% |
| Return on Tangible Assets | -172.09% | -51.27% | -45.35% | -18.15% | -41.12% |
| Earnings Yield | -733.56% | -94.87% | -45.13% | -6.97% | -1.87% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.52 | 1.46 | 0.00 | 0.20 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 8.77 | 0.54 | 0.31 | 0.30 | 0.00 |
| Asset Turnover | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 240.13 | 249.74 | 0.00 | 1795.80 | 0.00 |
| Days of Sales Outstanding | 240.13 | 249.74 | 0.00 | 1795.80 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 240.13 | 249.74 | 0.00 | 1795.80 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.05 | -0.03 | -0.05 | -0.04 | -0.02 |
| Free Cash Flow Per Share | -0.05 | -0.05 | -0.07 | -0.06 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -13.56 | -2.24 | -2.96 | -1.28 | -54.17 |
| Capital Expenditure Coverage Ratio | -13.56 | -2.24 | -2.96 | -1.28 | -54.17 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -64.22 | -277.58 | -478.89 | -190.88 | 0.00 |
| Free Cash Flow Yield | -741.00% | -114.11% | -59.06% | -10.03% | -1.62% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.14 | -1.05 | -2.22 | -14.35 | -53.46 |
| Price-to-Sales (P/S) Ratio | 9.31 | 351.68 | 1084.41 | 3387.06 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.09 | 0.34 | 0.78 | 2.40 | 19.19 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.13 | -0.88 | -1.69 | -9.97 | -61.54 |
| Price-to-Operating Cash Flow Ratio | -0.14 | -1.27 | -2.26 | -17.74 | -62.68 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.04 | -0.10 | -0.10 | 0.00 |
| Enterprise Value Multiple | 0.46 | 0.84 | -0.05 | -8.98 | -51.11 |
| Enterprise Value | -3.28M | -5.48M | 434.41K | 52.69M | 77.80M |
| EV to EBITDA | 0.46 | 0.84 | -0.05 | -8.98 | -51.11 |
| EV to Sales | -28.80 | -288.63 | 24.13 | 2107.78 | 0.00 |
| EV to Free Cash Flow | 0.42 | 0.72 | -0.04 | -6.20 | -58.76 |
| EV to Operating Cash Flow | 0.45 | 1.04 | -0.05 | -11.04 | -59.84 |
| Tangible Book Value Per Share | 0.03 | 0.07 | 0.12 | 0.24 | 0.04 |
| Shareholders’ Equity Per Share | 0.07 | 0.12 | 0.16 | 0.27 | 0.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.05 | -0.04 | -0.05 | -0.04 | -0.02 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.97 | 0.97 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 32.94 | 0.88 | 0.00 |
| SG&A to Revenue | 28.68 | 103.32 | 490.44 | 237.08 | 0.00 |
| Stock-Based Compensation to Revenue | 0.11 | 1.26 | 3.44 | 5.56 | 0.00 |
| Income Quality | 0.91 | 0.78 | 0.98 | 0.81 | 0.85 |
Currency in USD